Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Genet Med. 2014 Dec 11;17(8):644–650. doi: 10.1038/gim.2014.163

Table 4. Importance of available resources for return of secondary findings to research participants1.

Resource Essential
% (n)
Important
% (n)
Somewhatimportant
% (n)
Notimportant
% (n)
Qualified staff and/or genetic counselors to educate participants (N=190) 72.2% (143) 17.7% (35) 5.1% (10) 1.0% (2)
Well curated mutation and polymorphism databases (N=188) 59.6% (118) 26.3% (52) 7.1% (14) 2.0% (4)
Guidance for IRBs on returning secondary findings (N=189) 52.0% (103) 29.3% (58) 13.1% (26) 1.0% (2)
Accessible software to efficiently analyze sequence data (N=187) 46.5% (92) 29.3% (58) 15.7% (31) 3.0% (6)
Funding for clinical confirmation of research results in a CLIA laboratory (N=188) 40.9% (81) 30.8% (61) 19.2% (38) 4.0% (8)
Recommended lists of genes for return (N=190) 33.3% (66) 31.8% (63) 22.2% (44) 8.6% (17)
Mechanisms to locate previously enrolled research participants (N=188) 25.8% (51) 38.9% (77) 24.2% (48) 6.1% (12)
Mechanisms to easily and effectively maintain contact with research participants (N=190) 25.3% (50) 48.5% (96) 19.7% (39) 2.5% (5)
Online or video educational materials to educate participants (N=188) 19.2% (38) 42.4% (84) 26.8% (53) 6.6% (13)
1

Percentages based on total number of respondents (N=198)